Wenbin Jiang
PRESIDENT AND CEO at Cytek Biosciences Inc.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cytek Biosciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cytek Biosciences Inc. June 5, 202486.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +11,781 | — | — |
| Aug 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −2,869 | $4.67 | $13,398 |
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +22,100 | — | — |
| Aug 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −5,382 | $4.67 | $25,134 |
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +29,002 | — | — |
| Aug 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −7,062 | $4.67 | $32,980 |
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +57,212 | — | — |
| Aug 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −20,956 | $4.67 | $97,865 |
| May 18, 2026 | Cytek Biosciences Inc. | Option exercise | +7,854 | — | — |
| May 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −1,913 | $3.55 | $6,791 |
| May 18, 2026 | Cytek Biosciences Inc. | Option exercise | +14,733 | — | — |
| May 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −3,588 | $3.55 | $12,737 |
| May 18, 2026 | Cytek Biosciences Inc. | Option exercise | +19,334 | — | — |
| May 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −5,032 | $3.55 | $17,864 |
| May 18, 2026 | Cytek Biosciences Inc. | Option exercise | +38,141 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.